The Embryo Research Licensing Committee (ERLC) maintains an online database of general and mitochondrial donation licences.
ERLC is required by section 29 of the Research Involving Human Embryos Act 2002 (RIHE Act) to maintain an online, public database containing following information on each general and mitochondrial donation licence.
The database includes information on:
- the activities authorised by a licence
- the number of human embryos, eggs, or zygotes to be created and/or used in a licensed activity
- the standard and special conditions a licence is subject to
- who a licence is issued to and its term.
Licence conditions
Licences are subject to standard and special conditions, these are legal requirements that must be followed by the licence holder and other authorised persons who carry out the licensed activities. Licences are also subject to the provisions of the RIHE Act and the Prohibition of Human Cloning for Reproduction Act 2002.
Standard conditions apply to all licences, unless they are specifically excluded by a Special condition. They are outlined in the RIHE Act (sections 24, 28N, 28P, 28Q) and are available in the downloads section.
Special conditions regulate the specific activities authorised under each licence. This may include information such as the number of excess ART embryos, eggs or zygotes authorised for use, the number of other embryos authorised to be created or used, sites where the authorised activities will occur, and any other conditions determined by ERLC.
Database
Active Licences
Active licences are available in the Downloads section.
| Licence no. | Organisation | Licence title | Date of issue | Expiry date |
|---|---|---|---|---|
| General - 309727 | Melbourne IVF Pty Ltd | Comprehensive chromosomal analysis of human preimplantation embryos | 15 August 2022 | 14 August 2027 |
| General - 309729 | Monash University | The generation and study of a novel in-vitro model of human blastocysts (‘iBlastoids’) | 19 October 2022 | 18 October 2027 |
Expired Licences
To request more information about an expired licence, email embryo.research@nhmrc.gov.au.
| Licence no. | Organisation | Licence title | Date of issue | Expiry date |
|---|---|---|---|---|
| 309700 | Monash IVF | Use of excess ART embryos for training in embryo biopsy | 11 March 2005 | 11 March 2008 |
| 309701 | Sydney IVF | Improvement in laboratory conditions for embryo culture | 16 April 2004 | 28 March 2012 |
| 309702A | Sydney IVF | Effect of an additive on embryo culture: analysis of growth and epigenetic programming | 16 April 2004 | 28 March 2012 |
| 309702b | Genea Limited | Development of Methods for Preimplantation Genetic and Metabolic Evaluation of Human Embryos | 16 April 2004 | 14 February 2023 |
| 309703 | Genea Limited | Development of Human Embryonic Stem (ES) Cells | 16 April 2004 | 14 February 2023 |
| 309704 | Melbourne IVF Pty Ltd | Development of testing procedures for unbalanced chromosome errors in human embryos | 16 April 2004 | 16 April 2013 |
| 309707 | Monash University | Derivation of embryonic stem cell lines from the human embryo | 21 December 2004 | 21 December 2007 |
| 309708 | IVF Australia Pty Ltd | A collaborative project between IVF Australia and the Diabetes Transplant Unit, Prince of Wales Hospital to derive human embryonic stem cell lines for the treatment of diabetes | 5 November 2004 | 5 November 2008 |
| 309709 | Melbourne IVF Pty Ltd | A collaborative project between Melbourne IVF Pty Ltd and Stem Cell Sciences Pty Ltd to derive human embryonic stem cell lines | 11 June 2004 | 16 November 2009 |
| 309710 | Genea Limited | Derivation of human embryonic stem cells from embryos identified through preimplantation genetic diagnosis to be affected by known serious monogenic conditions | 7 May 2007 | 14 February 2023 |
| 309712 | Genea Limited | Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from human cumulus cells into clinically unusable human eggs. | 16 September 2008 | 16 December 2015 |
| 309713 | Genea Limited | Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from adult human fibroblasts into clinically unusable human eggs. | 16 September 2008 | 16 December 2015 |
| 309714 | Genea Limited | Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from previously established human embryonic stem cell lines into clinically unusable human eggs. | 16 September 2008 | 16 December 2015 |
| 309716 | Fertility Australia Trust trading as Fertility East Assisted Conception Clinic and Monash Institute of Medical Research | Production of human embryonic stem cell lines from parthenogenetic activation of matured human eggs obtained from clinically unusable human eggs | 29 June 2011 | 29 December 2013 |
| 309720 | Fertility Australia Trust trading as Fertility East Assisted Conception Clinic and Division of Biological Engineering, Faculty of Engineering, Monash University | Production of human embryonic stem cell lines from parthenogenetic activation of human eggs obtained from ovaries removed prophylactically from women at risk for developing cancer | 15 July 2013 | 23 September 2014 |
| 309722 | Monash IVF Pty Ltd | Optimising embryo-endometrial interactions to improve pregnancy success during IVF | 11 December 2013 | 11 December 2016 |
| 309723 | Melbourne IVF Pty Ltd | Use of excess ART embryos for blastocyst-stage biopsy training | 19 December 2014 | 19 December 2020 |
| 309724 | IVF Australia Pty Ltd | Use of excess ART embryos for blastocyst-stage biopsy training | 21 April 2017 | 21 April 2020 |
| 309725 | TasIVF Pty Ltd | Use of excess ART embryos for blastocyst-stage embryo biopsy training | 1 September 2017 | 1 September 202 |
| 309726 | Genea Limited | Use of excess ART embryos for training in an alternate biopsy method (day five hatch and biopsy) | 3 June 2019 | 14 February 2023 |
| 309718 | Genea Limited | Use of excess ART embryos and clinically unusable eggs for validation of an IVF device | 8 December 2011 | 7 December 2024 |
| 309719 | Genea Limited | Use of excess ART embryos for the development of improved IVF culture media | 28 March 2012 | 7 December 2024 |
